Please login to the form below

Leo Pharma

This page shows the latest Leo Pharma news and features for those working in and with pharma, biotech and healthcare.

MorphoSys drops Novartis-partnered drug in eczema after phase 2 miss

There are a number of drugs coming through the collective industry pipeline as well, including IL-13 inhibitors from Dermira (lebrikizumab) and Leo Pharma (tralokinumab) and oral JAK inhibitors such as

Latest news

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

Extends reach of the drug. Leo Pharma has acquired the rights to develop and market psoriasis treatment brodalumab outside Europe. . ... Leo Pharma has had approval for brodalumab in the EU, which it markets under the name Kyntheum, since 2017.
New Awards scheme for medical and scientific professionals

The steering group, which is made up of representatives from the likes of Novo Nordisk, LEO Pharma, IQVIA and Gilead to name a few, is in the midst of finalising the
VCCP Health lands record haul at the PM Society Awards

The agency picked up 10 Golds for work on behalf of Teva and LEO Pharma. ... Target Award for Secondary Care Advertisement - Lime for Dexcom. Best Use of Insight - VCCP Health for LEO Pharma.
European Commission backs LEO Pharma’s Kyntheum

Drug has been approved to treat moderate-to-severe plaque psoriasis. European regulators have given the go-ahead for LEO Pharma’s Kyntheum (brodalumab) licensing it to treat moderate-to-severe ... Dr Sathish Kolli, medical director at LEO Pharma UK/IE,
Audit exposes gaps in pharma's promises on trial transparency

transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo Nordisk, Boehringer Ingelheim, Amgen, Merck &Co and AbbVie. ... The audit - which is published in the British Medical Journal - reveals that the commitments made by pharma companies

More from news
Approximately 15 fully matching, plus 17 partially matching documents found.

Latest Intelligence

Mapping the patient journey and minding the gap

The jury is still out on whether pharma can yet lay claim to being truly patient-centric. ... Similarly, LEO Pharma’s Voices in Partnership (ViP) programme brings together people with dermatological and thrombotic conditions so that it can better
Leo has its eyes on the prize

We are in an era of great change and treatment advances,” says Gitte Aabo, CEO and President of Leo Pharma. ... It makes it very attractive not only for Leo but for big pharma companies such as Novartis and Celgene that are very active in this area.
LEO: Patients benefit from transparency

One of those is LEO Pharma. Ranked second-best overall for its approach, AllTrials put it in first place for publishing both clinical study reports and summary results, and second place ... LEO Pharma announced its commitments to trial transparency back
Embracing digital disruption in pharma

This is what we did at LEO Pharma. As CEO of that independent unit, I believe we supplement the traditional model of offering medications by providing services and true holistic care. ... By setting up the LEO Innovation Lab, LEO Pharma is not simply
Deal Watch November 2016

acquisition - company. 125+. MorphoSys/ Leo Pharma. discovery and development of mAbs for skin diseases. ... licence. 115.5. Medivir | BioPhausia/ Karo Pharma. business with 13 established pharma drugs.

More from intelligence
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest appointments

New hires at Nanoform, Leo Pharma and Calliditas

Leo Pharma boosts Translational Medicine team. Adam Raff will soon join dermatology-focused Leo Pharma, heading up the company’s new Translational Medicine Unit as director and medical advisor. ... Adam Raff, Director, Translational Medicine Unit, Leo
Leo Pharma appoints new senior vice president

Gitte Aabo, president and chief executive officer of Leo Pharma, said: “Rhonda has extensive experience in pharmaceutical supply chain management, and she knows Leo Pharma really well. ... Duffy initially joined Leo Pharma back in 1993 and was
Pegasus expands pharma and life sciences senior team

From left: James Osborne, Yasmin Ghariani and Megan Hollingdale. Brighton-based Pegasus has expanded its pharma and life sciences senior team with three new appointments. ... Prior to this, Osborn worked at LEO Pharma, Roche Diagnostics and Weber
LEO Pharma appoints J&J's Michael Hinchy

LEO Pharma has appointed Michael Hinchy as its new dermatology director with responsibility for its UK and Ireland business. ... haematology. Geraldine Murphy, managing director of LEO Pharma UK/Ireland, said: “I am delighted to welcome Michael to lead
Takeda UK adds to its senior leadership team

She joins from LEO Pharma where she established professional and commercial HR practices to support a culture encouraging improved performance.

More from appointments
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest from PMHub

EPG Health

With an actionable reach of over a million HCPs globally, EPG Health provides customers (including most of the top 20 pharma companies) with an integrated toolset to:. ... Strategic planning - to ensure sustained engagement and ongoing success. Alexion,
Open Up Their World: Press Advert

Product: Self Promotion. Therapy area: Skin. View the PMHub profile for: VCCP Health.
VCCP Lands Record Haul at the PM Awards

VCCP Health won a record-breaking 10 Golds at the PM Society Awards for their work with Teva and LEO Pharma. ... Tracey Brader, Head Judge at the 2017 PM Society Awards, commented:“Best of Show winner ‘Give Nothing to Psoriasis’ by VCCP Health for
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation

A particularly interesting example was a project from LEO Pharma in which anyone can send molecules to them for testing for a potential role in treating skin diseases. ... This operates as a fully-transparent free service, with the only goal from LEO
Merck Serono, Pfizer, Novartis, Janssen and Lilly Meet to Debate the Future of Clinical Trials | eyeforpharma

Senior executives from Sanofi, Pfizer, GSK, Janssen, Amgen, Eli Lilly, Novo Nordisk, Daiichi Sankyo, LEO Pharma and Merck Serono, TEVA pharmaceuticals are all confirmed to speak at this high-level event. . ... And Thorsten Thormann, SVP New Product

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Lead Copywriter: Competitive

Medical Editor: Competitive

Healthcare Account Director: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Senior Account Manager: Competitive

Account Director – Creative Healthcare Communications: Competative

PMHub

Add my company

Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Sourcing R&D innovation: why pharma companies need to evolve their business models: Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?: 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...